1. Home
  2. BZH vs CRGX Comparison

BZH vs CRGX Comparison

Compare BZH & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZH
  • CRGX
  • Stock Information
  • Founded
  • BZH 1985
  • CRGX 2021
  • Country
  • BZH United States
  • CRGX United States
  • Employees
  • BZH N/A
  • CRGX N/A
  • Industry
  • BZH Homebuilding
  • CRGX
  • Sector
  • BZH Consumer Discretionary
  • CRGX
  • Exchange
  • BZH Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • BZH 666.1M
  • CRGX 190.0M
  • IPO Year
  • BZH 1994
  • CRGX 2023
  • Fundamental
  • Price
  • BZH $23.58
  • CRGX $4.46
  • Analyst Decision
  • BZH Strong Buy
  • CRGX Hold
  • Analyst Count
  • BZH 3
  • CRGX 7
  • Target Price
  • BZH $33.00
  • CRGX $4.67
  • AVG Volume (30 Days)
  • BZH 320.1K
  • CRGX 502.9K
  • Earning Date
  • BZH 07-31-2025
  • CRGX 08-11-2025
  • Dividend Yield
  • BZH N/A
  • CRGX N/A
  • EPS Growth
  • BZH N/A
  • CRGX N/A
  • EPS
  • BZH 3.10
  • CRGX N/A
  • Revenue
  • BZH $2,436,131,000.00
  • CRGX N/A
  • Revenue This Year
  • BZH N/A
  • CRGX $57.81
  • Revenue Next Year
  • BZH $14.27
  • CRGX N/A
  • P/E Ratio
  • BZH $7.60
  • CRGX N/A
  • Revenue Growth
  • BZH 13.50
  • CRGX N/A
  • 52 Week Low
  • BZH $17.37
  • CRGX $3.00
  • 52 Week High
  • BZH $38.22
  • CRGX $25.45
  • Technical
  • Relative Strength Index (RSI)
  • BZH 63.10
  • CRGX 57.89
  • Support Level
  • BZH $21.88
  • CRGX $4.09
  • Resistance Level
  • BZH $24.30
  • CRGX $4.51
  • Average True Range (ATR)
  • BZH 0.83
  • CRGX 0.18
  • MACD
  • BZH 0.17
  • CRGX 0.00
  • Stochastic Oscillator
  • BZH 79.87
  • CRGX 77.18

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

Share on Social Networks: